TY - JOUR
T1 - Defects in pre-mRNA processing as causes of and predisposition to diseases
AU - Stoilov, Peter
AU - Meshorer, Eran
AU - Gencheva, Marieta
AU - Glick, David
AU - Soreq, Hermona
AU - Stamm, Stefan
PY - 2002
Y1 - 2002
N2 - Humans possess a surprisingly low number of genes and intensively use pre-mRNA splicing to achieve the high molecular complexity needed to sustain normal body functions and facilitate responses to altered conditions. Because hundreds of thousands of proteins are generated by 25,000 to 40,000 genes, pre-mRNA processing events are highly important for the regulation of human gene expression. Both inherited and acquired defects in pre-mRNA processing are increasingly recognized as causes of human diseases, and almost all premRNA processing events are controlled by a combination of protein factors. This makes defects in these processes likely candidates for causes of diseases with complicated inheritance patterns that affect seemingly unrelated functions. The elucidation of genetic mechanisms regulating pre-mRNA processing, combined with the development of drugs targeted at consensus RNA sequences and/or corresponding proteins, can lead to novel diagnostic and therapeutic approaches.
AB - Humans possess a surprisingly low number of genes and intensively use pre-mRNA splicing to achieve the high molecular complexity needed to sustain normal body functions and facilitate responses to altered conditions. Because hundreds of thousands of proteins are generated by 25,000 to 40,000 genes, pre-mRNA processing events are highly important for the regulation of human gene expression. Both inherited and acquired defects in pre-mRNA processing are increasingly recognized as causes of human diseases, and almost all premRNA processing events are controlled by a combination of protein factors. This makes defects in these processes likely candidates for causes of diseases with complicated inheritance patterns that affect seemingly unrelated functions. The elucidation of genetic mechanisms regulating pre-mRNA processing, combined with the development of drugs targeted at consensus RNA sequences and/or corresponding proteins, can lead to novel diagnostic and therapeutic approaches.
UR - http://www.scopus.com/inward/record.url?scp=0036927671&partnerID=8YFLogxK
U2 - 10.1089/104454902320908450
DO - 10.1089/104454902320908450
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 12489991
AN - SCOPUS:0036927671
SN - 1044-5498
VL - 21
SP - 803
EP - 818
JO - DNA and Cell Biology
JF - DNA and Cell Biology
IS - 11
ER -